Skip to main content
logo
TriCo Bancshares (TCBK)
NASDAQ: TCBK · Real-Time Price · USD
41.14
-0.12 (-0.29%)
At close: Aug 6, 2025, 4:00 PM
41.18
+0.04 (0.10%)
After-hours: Aug 6, 2025, 4:10 PM EDT

Verve Therapeutics Revenue

TriCo Bancshares had revenue of $98.94M in the quarter ending June 30, 2025, with 1.52% growth. This brings the company's revenue in the last twelve months to $385.49M, down -0.72% year-over-year. In the year 2024, TriCo Bancshares had annual revenue of $389.19M, down -1.24%.

Revenue (ttm)
$385.49M
Revenue Growth
-0.72%
P/S Ratio
3.52
Revenue / Employee
$328,915
Employees
1,172
Market Cap
1.35B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024389.19M-4.87M-1.24%
Dec 31, 2023394.06M2.75M0.70%
Dec 31, 2022391.31M49.60M14.51%
Dec 31, 2021341.72M72.17M26.78%
Dec 31, 2020269.54M-41.82M-13.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Berkshire Hathaway370.15B
JPMorgan Chase & Co.163.65B
Bank of America98.46B
Wells Fargo & Company77.62B
Morgan Stanley65.61B
American Express Company63.44B
HSBC Holdings56.21B
The Goldman Sachs Group54.79B
Revenue Rankings

TCBK News

More News